SCHEMBL7547157

SCHEMBL7547157

COc1cccc2c(-c3cncc(-c4ccc(Cl)cc4)c3)cn(CCN3CCC(C#N)CC3)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 9/20 0.40
KDR P35968 4/20 0.38
FLT1 P17948 3/20 0.37
FLT4 P35916 3/20 0.37
AVPR1B P47901 1/20 0.36
CHRNB1 P11230 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNB3 Q05901 1/20 0.35
PRKCQ Q04759 1/20 0.34
CNR1 P21554 2/20 0.33
HTR2A P28223 2/20 0.33
HTR1D P28221 1/20 0.33
HTR7 P34969 1/20 0.33
HTR2B P41595 1/20 0.33
HTR4 Q13639 1/20 0.33
CHEK1 O14757 1/20 0.33
ACHE P22303 1/20 0.33
SLC2A1 P11166 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7550496 0.93 CNR2 (0.38) CNR2KDRFLT1FLT4AVPR1B
SCHEMBL7553359 0.93 CNR2 (0.42) CNR2KDRFLT1FLT4AVPR1B
SCHEMBL7553431 0.93 CNR2 (0.42) CNR2KDRFLT1FLT4AVPR1B
SCHEMBL7550119 0.89 CNR2 (0.40) CNR2KDRFLT1FLT4AVPR1B
SCHEMBL7554271 0.87 KDR (0.49) CNR2KDRFLT1FLT4CHRNB1
SCHEMBL7547303 0.87 KDR (0.53) CNR2KDRFLT1FLT4AVPR1B
SCHEMBL7990572 0.86 KDR (0.50) CNR2KDRFLT1FLT4CNR1
SCHEMBL7557245 0.84 KDR (0.54) KDRFLT1FLT4CHRNB1CHRNB2
SCHEMBL7551238 0.83 KDR (0.40) CNR2KDRFLT1FLT4CHRNB1
SCHEMBL7552370 0.82 KDR (0.53) CNR2KDRFLT1FLT4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed